Erratum: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF (Gene Therapy (2005) vol. 12 (452-460) 10.1038/sj.gt.3302421)

L. Buluwela, J. Pike, D. Mazhar, T. Kamalati, S. M. Hart, R. Al-Jehani, H. Yahaya, N. Patel, N. Sarwarl, D. A. Heathcote, O. Schwickerath, F. Phoenix, R. Hill, E. Aboagye, S. Shousha, J. Waxman, N. R. Lemoine, A. Zelent, R. C. Coombes, S. Ali

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalGene Therapy
Volume12
Issue number6
DOIs
StatePublished - Mar 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Buluwela, L., Pike, J., Mazhar, D., Kamalati, T., Hart, S. M., Al-Jehani, R., Yahaya, H., Patel, N., Sarwarl, N., Heathcote, D. A., Schwickerath, O., Phoenix, F., Hill, R., Aboagye, E., Shousha, S., Waxman, J., Lemoine, N. R., Zelent, A., Coombes, R. C., & Ali, S. (2005). Erratum: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF (Gene Therapy (2005) vol. 12 (452-460) 10.1038/sj.gt.3302421). Gene Therapy, 12(6). https://doi.org/10.1038/sj.gt.3302506